Sierra Oncology Inc
(SRRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRA | BCRX | EVO | ||
| Company | Sierra Oncology Inc | Biocryst Pharma Inc | Evotec Se | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.98 | 6.87 | 3.49 | ||
| High | 55.17 | 6.91 | 3.64 | ||
| Low | 54.98 | 6.72 | 3.49 | ||
| Latest | 54.99 | 6.76 | 3.51 | ||
| Change | +0.02 | -0.04 | +0.08 | ||
| % Change | +0.04% | -0.59% | +2.33% | ||
| Volume | 862,800 | 4,508,000 | 926,500 | ||
| 20-Day Average Volume | 396,690 | 4,364,770 | 177,570 | ||
| Previous Close | 54.97 | 6.80 | 3.43 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 54.91 | 6.64 | 3.60 | ||
| 20-Day Raw Stochastic | 62.96% | 56.38% | 29.55% | ||
| 20-Day Relative Strength | 77.35 | 47.49 | 50.22 | ||
| Weighted Alpha | +89.10 | -26.42 | -13.72 | ||
| Today's Opinion | 100% Buy | 72% Sell | 24% Sell | ||
| Previous Opinion | 100% Buy | 72% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 06/23/22 | +5.96% since 02/06/26 | -0.57% since 02/06/26 | ||
| Low | 54.65 on 06/24/22 | 6.26 on 02/09/26 | 3.39 on 02/12/26 | ||
| High | 55.19 on 06/24/22 | 6.91 on 02/13/26 | 3.69 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/27/22 | +0.15% since 01/13/26 | -9.30% since 01/13/26 | ||
| Low | 54.58 on 05/31/22 | 6.23 on 02/05/26 | 3.38 on 02/02/26 | ||
| High | 55.19 on 06/24/22 | 7.27 on 01/15/26 | 3.82 on 02/03/26 | ||
| 3-Month | |||||
| %Chg | +69.83% since 03/30/22 | -2.03% since 11/13/25 | +10.73% since 11/13/25 | ||
| Low | 30.87 on 03/31/22 | 6.23 on 02/05/26 | 2.86 on 12/09/25 | ||
| High | 55.19 on 06/24/22 | 8.17 on 12/04/25 | 3.87 on 01/13/26 | ||
| 6-Month | |||||
| %Chg | +144.40% since 12/30/21 | -20.75% since 08/13/25 | -7.87% since 08/13/25 | ||
| Low | 14.91 on 01/24/22 | 6.00 on 10/14/25 | 2.86 on 12/09/25 | ||
| High | 55.19 on 06/24/22 | 8.68 on 08/27/25 | 4.27 on 10/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,342,801 | 1,424,596 | 1,247,082 | ||
| Shares Outstanding, K | 24,419 | 210,739 | 355,294 | ||
| Annual Sales | 0 | 450,710,000 | 862,400,000 | ||
| Annual Net Income | -94,660,000 | -88,880,000 | -212,180,000 | ||
| Last Quarter Sales | 0 | 159,400,000 | 191,570,000 | ||
| Last Quarter Net Income | -27,930,000 | 12,900,000 | -50,360,000 | ||
| 60-Month Beta | 0.01 | 0.83 | 1.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.33 on 05/06/22 | 0.06 on 11/03/25 | N/A on 11/05/25 | ||
| Latest Earnings Date | 08/04/22 | 02/26/26 | 11/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 85.00 | 0.00 | ||